Literature DB >> 15920503

Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity.

Malini E Singh1, Iain S McGregor, Paul E Mallet.   

Abstract

In the present study, the effects of perinatal exposure to Delta(9)-tetrahydrocannabinol (THC) on heroin-induced place conditioning and Fos-immunoreactivity (Fos-IR) were examined. Male albino Wistar rats (N=104) were pretreated with vehicle (n=52) or 5 mg/kg THC (n=52) from postnatal days 4 through 14. At approximately 8 weeks of age, 72 rats were divided into six equal groups (n=12 per group) and injected subcutaneously (s.c.) with vehicle, 0.5, or 2.0 mg/kg heroin and tested in an unbiased two-compartment place conditioning task. In vehicle-pretreated rats, 2.0 mg/kg but not 0.5 mg/kg heroin produced a significant place preference. Perinatal THC exposure significantly enhanced the rewarding properties of both doses of heroin. In the second experiment, 32 rats were divided into four equal groups (n=8 per group) and injected with vehicle or 0.5 mg/kg heroin s.c. and perfused 2-h later. Fos-IR was examined in several brain regions directly or indirectly involved in reward. Acute administration of heroin in vehicle pretreated rats increased Fos-IR in the central, medial, and dorsomedial caudate putamen (CPu), nucleus accumbens (NAC, core and shell regions), lateral septum, islands of Calleja-major (ICjM), bed nucleus of the stria terminalis (BNST), central nucleus of the amygdala (CEA), dorsolateral and dorsomedial periaqueductal gray (PAG), ventral tegmental area (VTA), Edinger-Westphal nucleus (EW). Perinatal THC exposure significantly increased heroin-induced Fos-IR in the dorsomedial CPu. Conversely, perinatal THC exposure reduced heroin-induced Fos-IR in the NAC (shell), BNST, CEA, dorsolateral and lateral PAG, VTA, and EW. The present study demonstrates an increase in the rewarding properties of heroin following exposure to THC at an early age and provides new evidence regarding possible neural correlates underlying this behavioral alteration. Neuropsychopharmacology (2006) 31, 58-69. doi:10.1038/sj.npp.1300770; published online 25 May 2005.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15920503     DOI: 10.1038/sj.npp.1300770

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  15 in total

Review 1.  Cannabis use in pregnancy and early life and its consequences: animal models.

Authors:  Miriam Schneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-02       Impact factor: 5.270

2.  Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring.

Authors:  Jennifer A DiNieri; Xinyu Wang; Henrietta Szutorisz; Sabrina M Spano; Jasbir Kaur; Patrizia Casaccia; Diana Dow-Edwards; Yasmin L Hurd
Journal:  Biol Psychiatry       Date:  2011-08-05       Impact factor: 13.382

Review 3.  High times for cannabis: Epigenetic imprint and its legacy on brain and behavior.

Authors:  Henrietta Szutorisz; Yasmin L Hurd
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

4.  Cannabis as a Gateway Drug for Opioid Use Disorder.

Authors:  Arthur Robin Williams
Journal:  J Law Med Ethics       Date:  2020-06       Impact factor: 1.718

Review 5.  Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.

Authors:  Leigh V Panlilio; Zuzana Justinova
Journal:  Neuropsychopharmacology       Date:  2017-08-28       Impact factor: 7.853

6.  Repeated administration of a synthetic cannabinoid receptor agonist differentially affects cortical and accumbal neuronal morphology in adolescent and adult rats.

Authors:  A F Carvalho; B A S Reyes; F Ramalhosa; N Sousa; E J Van Bockstaele
Journal:  Brain Struct Funct       Date:  2014-10-28       Impact factor: 3.270

7.  Trajectory of adolescent cannabis use on addiction vulnerability.

Authors:  Yasmin L Hurd; Michael Michaelides; Michael L Miller; Didier Jutras-Aswad
Journal:  Neuropharmacology       Date:  2013-08-14       Impact factor: 5.250

Review 8.  The Edinger-Westphal nucleus: a historical, structural, and functional perspective on a dichotomous terminology.

Authors:  Tamás Kozicz; Jackson C Bittencourt; Paul J May; Anton Reiner; Paul D R Gamlin; Miklós Palkovits; Anja K E Horn; Claudio A B Toledo; Andrey E Ryabinin
Journal:  J Comp Neurol       Date:  2011-06-01       Impact factor: 3.215

9.  Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users.

Authors:  Liam Nestor; Robert Hester; Hugh Garavan
Journal:  Neuroimage       Date:  2009-07-23       Impact factor: 6.556

10.  Long-term consequences of perinatal fatty acid amino hydrolase inhibition.

Authors:  Chia-Shan Wu; Daniel Morgan; Chris P Jew; Chris Haskins; Mary-Jeanette Andrews; Emma Leishman; Corinne M Spencer; Traci Czyzyk; Heather Bradshaw; Ken Mackie; Hui-Chen Lu
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.